Jonathan Young - 13 Sep 2023 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role: Chief Operating Officer
Signature: /s/ Jonathan Young
Issuer symbol: AKRO
Transactions as of: 13 Sep 2023
Net transactions value: -$28,291
Form type: 4
Filing time: 25 Sep 2023, 20:28:46 UTC
Previous filing: 15 Jun 2023
Next filing: 04 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AKRO	Common Stock	Sale	$28,291	-562	-0.31%	$50.34	183,177	13 Sep 2023	Direct	F1
holding	AKRO	Common Stock						20,000	13 Sep 2023	By EA Irrevocable Trust	F2
holding	AKRO	Common Stock						20,000	13 Sep 2023	By CM Irrevocable Trust	F2
holding	AKRO	Common Stock						20,000	13 Sep 2023	By JL Irrevocable Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the reporting person. The sales reported on this Form 4 represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. Such sales were automatic and intended to qualify under Rule 10b5-1.
F2	These shares are held in irrevocable trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the reporting person. The sales reported on this Form 4 represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. Such sales were automatic and intended to qualify under Rule 10b5-1.

These shares are held in irrevocable trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.